Molecular Mechanisms of Apoptosis of Glomerular Podocytes in Diabetic Nephropathy

被引:0
作者
Shpakov, A. O. [1 ]
Kaznacheyeva, E., V [2 ]
机构
[1] Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg 194223, Russia
[2] Russian Acad Sci, Cytol Inst, St Petersburg 194064, Russia
来源
BIOLOGICHESKIE MEMBRANY | 2020年 / 37卷 / 04期
关键词
diabetic nephropathy; podocyte; apoptosis; calcium channel TRPC6; mTORC complex; Wnt/beta-catenin pathway; GTPase of the Rho family; TO-MESENCHYMAL TRANSITION; ENDOPLASMIC-RETICULUM STRESS; EPITHELIUM-DERIVED FACTOR; NF-KAPPA-B; CATENIN SIGNALING PATHWAY; PHOSPHOLIPASE-C-EPSILON; SMOOTH-MUSCLE ACTIN; KIDNEY-DISEASE; ANGIOTENSIN-II; RENAL INJURY;
D O I
10.31857/S0233475520030056
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Dysfunctions of glomerular podocytes and triggering of apoptotic processes in them are the main molecular causes of diabetic nephropathy and other kidney diseases. Pathogenetic factors causing these dysfunctions of podocytes are hyperglycemia, increased levels of advanced glycation end-products, oxidative stress, increased activity of inflammatory factors, and endoplasmic reticulum stress. These factors and their combinations result in the triggering of a number of intracellular signaling pathways that cause activation of apoptosis and reduce the survival of podocytes. Among these pathways are: (1) the Wnt/beta-catenin pathway, which is activated by the Wnt-proteins when they bind to the complex of Frizzled receptors and LRP co-receptors; (2) the mTOR-dependent signaling pathway, including the mTORC1 and mTORC2 complexes, which are involved in the regulation of autophagy and endoplasmic reticulum stress and are regulated by various stimuli and effectors, the AMP-activated protein kinase in particular; (3) the Rho/ROCK signaling pathway, including GTPases of the Rho family and Rho-associated protein kinase ROCK1; (4) calcium-dependent signaling pathways triggered by an increase in the concentration of intracellular Ca2+, primarily through the activation of calcium channels of the TRPC family. The review provides a detailed analysis of the current state of knowledge about the molecular mechanisms responsible for the regulation of apoptotic processes in glomerular podocytes and also considers hormonal and other factors that regulate them both in norm and in lesions induced by hyperglycemia and diabetic nephropathy.
引用
收藏
页码:243 / 263
页数:21
相关论文
共 50 条
  • [21] Diabetic Nephropathy: Novel Molecular Mechanisms and Therapeutic Targets
    Zoja, Carlamaria
    Xinaris, Christodoulos
    Macconi, Daniela
    [J]. FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [22] Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats
    Chen, Jianguo
    Chen, Yifang
    Luo, Yunling
    Gui, Dingkun
    Huang, Jianhua
    He, Dongyuan
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 736 : 86 - 94
  • [23] Nicotine, smoking, podocytes, and diabetic nephropathy
    Jaimes, Edgar A.
    Zhou, Ming-Sheng
    Siddiqui, Mohammed
    Rezonzew, Gabriel
    Tian, Runxia
    Seshan, Surya, V
    Muwonge, Alecia N.
    Wong, Nicholas J.
    Azeloglu, Evren U.
    Fornoni, Alessia
    Merscher, Sandra
    Raij, Leopoldo
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2021, 320 (03) : F442 - F453
  • [24] Activation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions
    Lee, Sun Ha
    Yoo, Tae-Hyun
    Nam, Bo-Young
    Kim, Dong Ki
    Li, Jin Ji
    Jung, Dong-Sub
    Kwak, Seung-Jae
    Ryu, Dong-Ryeol
    Han, Seung Hyeok
    Lee, Jung Eun
    Moon, Sung Jin
    Han, Dae Suk
    Kang, Shin-Wook
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2009, 297 (05) : F1381 - F1390
  • [25] Hypertrophy and Loss of Podocytes in Diabetic Nephropathy
    Miyauchi, Masaaki
    Toyoda, Masao
    Kobayashi, Keiko
    Abe, Makiko
    Kobayashi, Takako
    Kato, Mayuko
    Yamamoto, Naoyuki
    Kimura, Moritsugu
    Umezono, Tomoya
    Suzuki, Daisuke
    [J]. INTERNAL MEDICINE, 2009, 48 (18) : 1615 - 1620
  • [26] Melatonin protects podocytes from angiotensin II-induced injury in an in vitro diabetic nephropathy model
    Ji, Zhen-Zhong
    Xu, Yan-Cheng
    [J]. MOLECULAR MEDICINE REPORTS, 2016, 14 (01) : 920 - 926
  • [27] Diabetic nephropathy: New insights into established therapeutic paradigms and novel molecular targets
    Sharma, Dilip
    Bhattacharya, Pallab
    Kalia, Kiran
    Tiwari, Vinod
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 128 : 91 - 108
  • [28] Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy
    Jourdan, Tony
    Szanda, Gergo
    Rosenberg, Avi Z.
    Tam, Joseph
    Earley, Brian James
    Godlewski, Grzegorz
    Cinar, Resat
    Liu, Ziyi
    Liu, Jie
    Ju, Cynthia
    Pacher, Pal
    Kunos, George
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (50) : E5420 - E5428
  • [29] An Overview of the Posttranslational Modifications and Related Molecular Mechanisms in Diabetic Nephropathy
    Cao, Yu
    Yang, Zhao
    Chen, Ying
    Jiang, Shuai
    Wu, Zhen
    Ding, Baoping
    Yang, Yang
    Jin, Zhenxiao
    Tang, Haifeng
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [30] Molecular mechanisms in the pathogenesis of diabetic nephropathy: An update
    Arora, Mandeep Kumar
    Singh, Umesh Kumar
    [J]. VASCULAR PHARMACOLOGY, 2013, 58 (04) : 259 - 271